The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Cellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859
The emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,630
Freeze-drying of nanoparticles: Formulation, process and storage considerations
ABDELWAHED, W., DEGOBERT, G., STAINMESSE, S., & FESSI, H. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.017 · Cited by 1,611
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,411
Mechanisms of nanotoxicity: Generation of reactive oxygen species
Fu, P. P., Xia, Q., Hwang, H.-M., Ray, P. C., & Yu, H. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.01.005 · Cited by 1,398
Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delie, F. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,081
The Smart Drug Delivery System and Its Clinical Potential
Liu, D., Yang, F., Xiong, F., & Gu, N. (2016) · Theranostics · doi:10.7150/thno.14858 · Cited by 1,066
Xiao, K., Li, Y., Luo, J., Lee, J. S., Xiao, W., Gonik, A. M., Agarwal, R. G., & Lam, K. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.021 · Cited by 1,039
Nanocrystal technology, drug delivery and clinical applications
Müller, R., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 953
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
Vauthier, C., & Bouchemal, K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9800-3 · Cited by 929
Limbach, L. K., Wick, P., Manser, P., Grass, R. N., Bruinink, A., & Stark, W. J. (2007) · Environmental Science & Technology · doi:10.1021/es062629t · Cited by 889
Quality by design for biopharmaceuticals
Rathore, A. S., & Winkle, H. (2009) · Nature Biotechnology · doi:10.1038/nbt0109-26 · Cited by 830
The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles
Cho, E. C., Zhang, Q., & Xia, Y. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.58 · Cited by 719
Techniques for physicochemical characterization of nanomaterials
Lin, P.-C., Lin, S., Wang, P. C., & Sridhar, R. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.11.006 · Cited by 708
Microfluidic technologies for accelerating the clinical translation of nanoparticles
Valencia, P. M., Farokhzad, O. C., Karnik, R., & Langer, R. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.168 · Cited by 698
The Impact of Nanoparticle Protein Corona on Cytotoxicity, Immunotoxicity and Target Drug Delivery
Corbo, C., Molinaro, R., Parodi, A., Toledano Furman, N. E., Salvatore, F., & Tasciotti, E. (2016) · Nanomedicine · doi:10.2217/nnm.15.188 · Cited by 692
Anselmo, A. C., Zhang, M., Kumar, S., Vogus, D. R., Menegatti, S., Helgeson, M. E., & Mitragotri, S. (2015) · ACS Nano · doi:10.1021/acsnano.5b00147 · Cited by 643
Shaping Cancer Nanomedicine: The Effect of Particle Shape on The In Vivo Journey of Nanoparticles
Toy, R., Peiris, P. M., Ghaghada, K. B., & Karathanasis, E. (2014) · Nanomedicine · doi:10.2217/nnm.13.191 · Cited by 570
In vitro assessments of nanomaterial toxicity
Jones, C. F., & Grainger, D. W. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.005 · Cited by 554
Quality by Design in Biopharmaceuticals
Yang, H. (2016) · doi:10.1201/9781315371726-7 · Cited by 543
Multifunctional Nanoparticles for Drug Delivery and Molecular Imaging
Bao, G., Mitragotri, S., & Tong, S. (2013) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071812-152409 · Cited by 536
Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma
Song, Y., Li, X., & Du, X. (2009) · European Respiratory Journal · doi:10.1183/09031936.00178308 · Cited by 448
The Future of Pharmaceutical Manufacturing Sciences
Rantanen, J., & Khinast, J. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24594 · Cited by 442
Regulatory aspects on nanomedicines
Sainz, V., Conniot, J., Matos, A. I., Peres, C., Zupanǒiǒ, E., Moura, L., Silva, L. C., Florindo, H. F., & Gaspar, R. S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.023 · Cited by 417
Effect of ligand density, receptor density, and nanoparticle size on cell targeting
Elias, D. R., Poloukhtine, A., Popik, V., & Tsourkas, A. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.05.015 · Cited by 404
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Ragelle, H., Danhier, F., Préat, V., Langer, R., & Anderson, D. G. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1244187 · Cited by 390
Impact of particle elasticity on particle-based drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.007 · Cited by 385
Organ-on-a-chip platforms for studying drug delivery systems
Bhise, N. S., Ribas, J., Manoharan, V., Zhang, Y. S., Polini, A., Massa, S., Dokmeci, M. R., & Khademhosseini, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.004 · Cited by 381
Li, Y., Kröger, M., & Liu, W. K. (2015) · Nanoscale · doi:10.1039/c5nr02970h · Cited by 376
The evolving landscape of drug products containing nanomaterials in the United States
D'Mello, S. R., Cruz, C. N., Chen, M.-L., Kapoor, M., Lee, S. L., & Tyner, K. M. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.67 · Cited by 345
Ball, R., Bajaj, P., & Whitehead, K. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s123062 · Cited by 333
Evolution and clinical translation of drug delivery nanomaterials
Hassan, S., Prakash, G., Bal Ozturk, A., Saghazadeh, S., Farhan Sohail, M., Seo, J., Remzi Dokmeci, M., Zhang, Y. S., & Khademhosseini, A. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.008 · Cited by 288
Crist, R. M., Grossman, J. H., Patri, A. K., Stern, S. T., Dobrovolskaia, M. A., Adiseshaiah, P. P., Clogston, J. D., & McNeil, S. E. (2013) · Integrative Biology · doi:10.1039/c2ib20117h · Cited by 265
Jindal, A. B. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.028 · Cited by 241
Liu, D., Zhang, H., Fontana, F., Hirvonen, J. T., & Santos, H. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.003 · Cited by 238
Joris, F., Manshian, B. B., Peynshaert, K., De Smedt, S. C., Braeckmans, K., & Soenen, S. J. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60145e · Cited by 236
Microfluidics‐based 3D cell culture models: Utility in novel drug discovery and delivery research
Gupta, N., Liu, J. R., Patel, B., Solomon, D. E., Vaidya, B., & Gupta, V. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10013 · Cited by 236
Dobrovolskaia, M. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.056 · Cited by 221
Lemoine, D., Francois, C., Kedzierewicz, F., Preat, V., Hoffman, M., & Maincent, P. (1996) · Biomaterials · doi:10.1016/0142-9612(96)00049-x · Cited by 219
Endotoxin Contamination: A Key Element in the Interpretation of Nanosafety Studies
Li, Y., & Boraschi, D. (2016) · Nanomedicine · doi:10.2217/nnm.15.196 · Cited by 196
Personalized Nanomedicine: A Revolution at the Nanoscale
Fornaguera, C., & García-Celma, M. (2017) · Journal of Personalized Medicine · doi:10.3390/jpm7040012 · Cited by 190
Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles
Galindo-Rodríguez, S. A., Puel, F., Briançon, S., Allémann, E., Doelker, E., & Fessi, H. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.03.013 · Cited by 183
Stimuli‐Responsive Polymeric Nanoparticles for Nanomedicine
Crucho, C. I. C. (2015) · ChemMedChem · doi:10.1002/cmdc.201402290 · Cited by 173
Vetten, M. A., Yah, C. S., Singh, T., & Gulumian, M. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.03.017 · Cited by 172
Mechanisms and measurements of nanomaterial-induced oxidative damage to DNA
Petersen, E. J., & Nelson, B. C. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3881-7 · Cited by 169
Agrahari, V., & Hiremath, P. S. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0039 · Cited by 164
Self-citationThe impact of nanoparticle ligand density on dendritic-cell targeted vaccines
Bandyopadhyay, A., Fine, R. L., Demento, S., Bockenstedt, L. K., & Fahmy, T. M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.054 · Cited by 141
Ranjan, A. P., Mukerjee, A., Helson, L., & Vishwanatha, J. K. (2012) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-10-38 · Cited by 141
Issues and concerns in nanotech product development and its commercialization
Kaur, I. P., Kakkar, V., Deol, P. K., Yadav, M., Singh, M., & Sharma, I. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.005 · Cited by 140
Nanocarrier Fabrication and Macromolecule Drug delivery: Challenges and Opportunities
Agrahari, V., Agrahari, V., & Mitra, A. K. (2016) · Therapeutic Delivery · doi:10.4155/tde-2015-0012 · Cited by 137
Self-citationChallenges Posed by The Scale-Up of Nanomedicines
Muthu, M. S., & Wilson, B. (2012) · Nanomedicine · doi:10.2217/nnm.12.3 · Cited by 134
Irvine, D. J. (2011) · Nature Materials · doi:10.1038/nmat3014 · Cited by 134
Contamination of nanoparticles by endotoxin: evaluation of different test methods
Smulders, S., Kaiser, J., Zuin, S., LANDUYT, K. L. V., Golanski, L., Vanoirbeek, J. A., Wick, P., & Hoet, P. (2012) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-9-41 · Cited by 132
Nanoparticle Surface Functionality Dictates Cellular and Systemic Toxicity
Saei, A. A., Yazdani, M., Lohse, S. E., Bakhtiary, Z., Serpooshan, V., Ghavami, M., Asadian, M., Mashaghi, S., Dreaden, E. C., Mashaghi, A., et al. (2017) · Chemistry of Materials · doi:10.1021/acs.chemmater.7b01979 · Cited by 120
Pallagi, E., Ambrus, R., Szabó‐Révész, P., & Csóka, I. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.06.018 · Cited by 111
Bozdag, S., Dillen, K., Vandervoort, J., & Ludwig, A. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357056145 · Cited by 107
Engineering multifunctional nanoparticles: all‐in‐one versus one‐for‐all
Huynh, E., & Zheng, G. (2013) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1217 · Cited by 105
Anselmo, A. C., Kumar, S., Gupta, V., Pearce, A. M., Ragusa, A., Muzykantov, V. R., & Mitragotri, S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.043 · Cited by 100
Nanosystem trends in drug delivery using quality-by-design concept
Li, J., Qiao, Y., & Wu, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.019 · Cited by 100
Endotoxin Contamination in Nanomaterials Leads to the Misinterpretation of Immunosafety Results
Li, Y., Fujita, M., & Boraschi, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00472 · Cited by 99
Influence of particle geometry and PEGylation on phagocytosis of particulate carriers
Mathaes, R., Winter, G., Besheer, A., & Engert, J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.02.037 · Cited by 95
Effect of Freeze-Drying Process Conditions on the Stability of Nanoparticles
Choi, M., Briançon, S., Andrieu, J., Min, S. G., & Fessi, H. (2004) · Drying Technology · doi:10.1081/drt-120028238 · Cited by 91
Transforming Nanomedicines From Lab Scale Production to Novel Clinical Modality
Landesman‐Milo, D., & Peer, D. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00607 · Cited by 88
Meng, J., Agrahari, V., & Youm, I. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9698-1 · Cited by 80
Self-citationA Quality by Design Approach to Developing and Manufacturing Polymeric Nanoparticle Drug Products
Troiano, G., Nolan, J., Parsons, D. M., Hoven, C. V. G., & Zale, S. E. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9969-z · Cited by 79
Product quality for nanomaterials: current U.S. experience and perspective
Tyner, K. M., Zou, P., Yang, X., Zhang, H., Cruz, C. N., & Lee, S. L. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1338 · Cited by 77
Project, Design, and Use of a Pilot Plant for Nanocapsule Production
Colombo, A. P., Briançon, S., Liéto, J., et al. (2001) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100108369 · Cited by 67
Zheng, J. (2011) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.s5-001 · Cited by 63
Zaloga, J., Janko, C., Agarwal, R., Nowak, J., Müller, R., Boccaccini, A. R., Lee, G., Odenbach, S., Lyer, S., & Alexiou, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16059368 · Cited by 55
Reviewing the Regulatory Barriers for Nanomedicine: Global Questions and Challenges
Bowman, D. M., & Gatof, J. (2015) · Nanomedicine · doi:10.2217/nnm.15.169 · Cited by 55
Future of Nanomedicine: Obstacles and Remedies
Bosetti, R., & Vereeck, L. (2011) · Nanomedicine · doi:10.2217/nnm.11.55 · Cited by 50
Early Development Challenges for Drug Products Containing Nanomaterials
Grossman, J. H., Crist, R. M., & Clogston, J. D. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9980-4 · Cited by 39
Yacasi, G. R. R., Calpena, A. C., Gras, M. A. E., Espina, M., & García, M. L. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1275669 · Cited by 35
Microfluidics for nano-pathophysiology
Sato, K., Sasaki, N., Svahn, H. A., & Satō, K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.009 · Cited by 28
Agglomeration, sedimentation, and cellular toxicity of alumina nanoparticles in cell culture medium
Yoon, D., Woo, D., Kim, J. H., Kim, M. K., Kim, T., Hwang, E., & Baik, S. (2010) · Journal of Nanoparticle Research · doi:10.1007/s11051-010-0147-4 · Cited by 26
Nakamura, K., Kiminami, H., Yamashita, A., Abe, Y., Yoshino, K., & Suzuki, S. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.02.020 · Cited by 16
Özcan, İ., Bouchemal, K., Segura‐Sánchez, F., Abacıa, Ö., Ozer, Ö., Güneri, T., & Ponchel, G. (2009) · Institutional Repository University of Antioquia (University of Antioquia) · Cited by 10
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Nanoparticles: Taking a Unique Position in Medicine
Joseph, T., Kar Mahapatra, D., Esmaeili, A., Piszczyk, Ł., Hasanin, M., Kattali, M., Haponiuk, J., & Thomas, S. (2023) · Nanomaterials · doi:10.3390/nano13030574 · Cited by 480
Effects of nanoparticle size, shape, and zeta potential on drug delivery
Öztürk, K., Kaplan, M., & Çalış, S. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124799 · Cited by 449
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs
Liu, Y., Liang, Y., Yuhong, J., Xin, P., Han, J. L., Du, Y., Yu, X., Zhu, R., Zhang, M., Chen, W., et al. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s447496 · Cited by 365
Metadata
- Authors
- Agrahari, V., & Agrahari, V.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 23
- Issue
- 5
- Pages
- 974-991
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2792311144
- Cited by
- 253
- References
- 84
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.